Aclo, Rolly V.
HRN: 08-01-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/23/2024
08/30/2024
1.5G
1.5g
Q6h
MULTIPLE PHYSICAL INJURY
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes